Neogen
Neogen is a leading US-based company providing comprehensive solutions for global food safety and animal health. It develops and markets innovative diagnostics, genomics tests, and biosecurity products to detect pathogens, allergens, and toxins. Neogen supports the agricultural, food, and veterinary medicine industries worldwide.
Recap: the latest results
Neogen (NEOG) reported its Q3 2026 financial results on October 6, 2026, after market close. The company announced earnings per share (EPS) of 0.08 USD, beating the analyst estimate of 0.05 USD by 60.0%. Quarterly revenue reached 223 million USD, and the stock price reacted with a decline of 2.16% following the release.
Generated automatically from our data — as of 10/08/2026 Read the article →
Frequently asked questions
When did Neogen last report quarterly earnings?
Neogen last reported quarterly earnings on 10/6/2026 (Q3 2026). Earnings per share (EPS) came in at 0.08 USD.
How does Neogen stock react to earnings?
Across its last 5 earnings reports, Neogen stock moved by ±15.8% on average the following day. The largest reaction was +31.6% on 01/08/2026; 3 of 5 reactions were positive.
How often has Neogen beaten expectations?
Neogen has beaten analyst EPS estimates in 5 of its last 6 evaluated quarters (beat rate: 83.3%).
How do I add the Neogen earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Stock reaction to earnings
Basis: price reactions to the last 5 report dates (close to close).
Estimates vs. results
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.